Linda Giudice

No ORCID on file · 9 papers in corpus · active 2005-2025

Study types

  • article 7
  • other 1
  • review 1

Condition tags

  • endometriosis 8
  • infertility 3
  • dysmenorrhea 2
  • dyspareunia 2
  • chronic_pelvic_pain 1
other 2025
bioRxiv : the preprint server for biology ·doi:10.1101/2025.07.21.666016

Endometriosis is a chronic, estrogen-dependent condition affecting over 190 million women globally, characterized by the ectopic presence of endometrial-like tissue that leads to inflammation, pain, and infertility. Despite its prevalence, …

article 2018
Contemporary clinical trials ·doi:10.1016/j.cct.2018.03.002
article 2018
Obstetrics and gynecology ·doi:10.1097/aog.0000000000002675

OBJECTIVE: To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain. METHODS: Elaris Endometriosis (EM)-III and -IV were exten…

article 2016

Copyright © 2015 Amelie Fassbender et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is…

review 2015
BioMed research international ·doi:10.1155/2015/130854

Endometriosis is histologically characterized by the displacement of endometrial tissue to extrauterine locations including the pelvic peritoneum, ovaries, and bowel. An important cause of infertility and pelvic pain, the individual and glo…

article 2013
Fertility and sterility ·doi:10.1016/j.fertnstert.2013.03.026
article 2013
Journal of endometriosis and pelvic pain disorders ·doi:10.5301/je.5000157

OBJECTIVE: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. METHODS: This was a phase II, randomized, placeb…

article 2010
·doi:10.1016/s0002-9378(10)00166-3
article 2005
Fertility and sterility ·doi:10.1016/j.fertnstert.2005.02.059